France Archives

News and Trends 17 Jan 2018

French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics

HalioDx hopes that its Immunoscore diagnostics platform can help to provide precision medicine for a number of indications, including colon cancer. HalioDx is an expert in cancer diagnostics, specializing in the analysis of the tumor microenvironment. The company has closed a €18.5M Series B financing round – impressive considering the concerns over reimbursement that investors often have for diagnostic […]

January 17, 2018 - 3 minutesmins - By Alex Dale

owkin artificial intelligence drug development

More News! 17 Jan 2018

€9M Round for AI Algorithms to Speed up Drug Development

Owkin has raised $11M(€9M) in a Series A round to fund its artificial intelligence platform for medical research and drug discovery. Owkin, based in New York and Paris, was founded in 2016 to develop machine learning algorithms that can deal with the overabundance of information in biology to optimize the drug development process. The company […]

January 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 17 Jan 2018

This French Biotech is Developing Kits to Stop Food Poisoning

Novolyze has raised €2.2M to bring its ready-to-use food safety kits to market as quickly as possible and help the hundreds of millions of people affected by food poisoning each year. Novolyze is a French biotech that develops products and services to reduce the risk of foodborne infections. It has raised €2.2M to accelerate its growth in markets […]

January 17, 2018 - 3 minutesmins - By Alex Dale

In Depth 17 Jan 2018

An Update on What’s New in the French Biotech Industry

Here’s a closer look at the French biotech ecosystem in 2017, which remains one the leading industries in Europe along with Germany and the UK. France’s biotech ecosystem is relatively dynamic and well-developed. Young companies harboring exciting technology are encouraged into the industry by support from Bpifrance, i-LAB, and iBionext. Once a company gets off the ground, France is […]

January 17, 2018 - 4 minutesmins - By Alex Dale

da volterra antibiotic resistance trial 1

News and Trends 16 Jan 2018

This French Biotech’s Medical Device Protects Against Antibiotic Resistance

Da Volterra has achieved impressive early results with its antibiotic resistance-busting medical device by successfully protecting the diversity of the microbiome. French biotech Da Volterra is developing products to fight the rapidly rising rates of antibiotic resistance. During a Phase I study, the company’s medical device, DAV132, was used with the antibiotic, moxifloxacin, and successfully protected the intestinal […]

January 16, 2018 - 2 minutesmins - By Alex Dale

News and Trends 11 Jan 2018

Carbios’ Bioplastics Can Now Be Infinitely Recycled at Scale

Scale-up is a major challenge in industrial biotech but Carbios has done it, going large-scale with its recyclable bioplastics technology. Carbios, a young and exciting green chemistry company, aims to find solutions to the environmental and sustainability issues faced by businesses. Since 2012, the company has been leading the THANAPLAST program, which has brought together academic and industrial […]

January 11, 2018 - 3 minutesmins - By Alex Dale

News and Trends 10 Jan 2018

New Venture Fund Closes $102M to Boost Biotech and Medical Device Development

Truffle Capital has raised $102M (€85M), which will support biotechs, with a focus on medical device companies that have the potential to become market leaders. Truffle Capital, founded in 2001 and based in Paris, is a venture capital firm that focuses on supporting start-ups in life sciences and IT. The company manages assets worth over $1.1B […]

January 10, 2018 - 2 minutesmins - By Alex Dale

gensight retinitis pigmentosa gene therapy

News and Trends 10 Jan 2018

French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa

GenSight will start a clinical trial in the UK testing a combination of gene therapy and a wearable device to restore sight in patients with retinitis pigmentosa. The UK Medicines and Healthcare Regulatory Agency (MHRA) has accepted GenSight’s application to run a first clinical trial in the UK testing a new type of therapy with the […]

January 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jan 2018

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

Enterome will use the money to progress two of its leading microbiome programs for the treatment of Crohn’s disease and an aggressive form of brain cancer. Enterome is a pioneer in the exciting field of microbiome-based therapies for diseases like inflammatory bowel diseases and cancer. This morning, the company has announced that it has raised €32M in […]

January 4, 2018 - 3 minutesmins - By Alex Dale

More News! 18 Dec 2017

French Biotech will work with the World’s Leader in Hearing Implants

Sensorion and Cochlear will explore if a combination of a drug and a hearing implant can improve the treatment of hearing loss. Based in the French city of Montpellier, Sensorion specializes in the development of treatments for inner ear disorders such as vertigo and hearing loss. The company’s technology received major recognition today with the […]

December 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Dec 2017

Abivax Spots an Extra Benefit of its Potential HIV Cure

Phase IIa data confirms that Abivax’s potential HIV cure not only reduces viral reservoir but it also has anti-inflammatory effects. Abivax targets the immune system to fight viral infections, including human immunodeficiency virus (HIV), as well as autoimmune diseases. The company has now confirmed the preliminary results from its first cohort of patients in a […]

December 15, 2017 - 2 minutesmins - By Alex Dale

News and Trends 13 Dec 2017

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Regeneron and Sanofi have announced positive early results from a Phase II study investigating their skin cancer antibody, cemiplimab. Despite deciding to end their antibody partnership at the end of the year, Regeneron and Sanofi are still committed to pushing through a number of candidates. One of these, cemiplimab, is a programmed cell death protein-1 (PD-1) checkpoint […]

December 13, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics

€9M Round for AI Algorithms to Speed up Drug Development

This French Biotech is Developing Kits to Stop Food Poisoning

An Update on What’s New in the French Biotech Industry

This French Biotech’s Medical Device Protects Against Antibiotic Resistance

Carbios’ Bioplastics Can Now Be Infinitely Recycled at Scale

New Venture Fund Closes $102M to Boost Biotech and Medical Device Development

French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

French Biotech will work with the World’s Leader in Hearing Implants

Abivax Spots an Extra Benefit of its Potential HIV Cure

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!